PMVP: PMV Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 46.53
Enterprise Value ($M) -4.81
Book Value ($M) 160.11
Book Value / Share 3.08
Price / Book 0.29
NCAV ($M) 153.00
NCAV / Share 2.95
Price / NCAV 0.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 16.75
Current Ratio 16.75

Balance Sheet (mrq) ($M)
Current Assets 163.50
Assets 170.61
Liabilities 10.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -84.85
Net Income -58.71

Cash Flow Statement (mra) ($M)
Cash From Operations -51.28
Cash from Investing 53.35
Cash from Financing 0.31

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-08 13G Sio Capital Management, LLC 7.19 4.57
02-21 13G PFM Health Sciences, LP 5.00
02-14 13G/A BML Investment Partners, L.P. 6.30 0.00
11-14 13G/A ArrowMark Colorado Holdings LLC 7.08 34.38
07-08 13G/A BlackRock, Inc. 2.30 -64.02
2024-04-09 13G/A Jpmorgan Chase & Co 0.00 -99.58

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 4,169 29,521 14.12
2025-05-08 2,116 250,753 0.84
2025-05-07 8,282 294,826 2.81
2025-05-06 57,624 747,034 7.71
2025-05-05 25,248 334,517 7.55

(click for more detail)

Similar Companies
PHAT – Phathom Pharmaceuticals, Inc. PHVS – Pharvaris N.V.
PLRX – Pliant Therapeutics, Inc. PRAX – Praxis Precision Medicines, Inc.
PRLD – Prelude Therapeutics Incorporated


Financial data and stock pages provided by
Fintel.io